{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:24:10Z","timestamp":1773865450419,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.revmed.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T16:46:22Z","timestamp":1473957982000},"page":"320-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Les infections opportunistes au cours de la sarco\u00efdose"],"prefix":"10.1016","volume":"38","author":[{"given":"Y.","family":"Jamilloux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kerever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.08.011_bib0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2016.08.011_bib0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.revmed.2016.01.010","article-title":"[Lung sarcoidosis: clinical features and therapeutic issues]","volume":"37","author":"Uzunhan","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.08.011_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/hci073","article-title":"Fungal infections as a complication of therapy for sarcoidosis","volume":"98","author":"Baughman","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.08.011_bib0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0025","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/WNL.0000000000000318","article-title":"Progressive multifocal leukoencephalopathy in patients with sarcoidosis","volume":"82","author":"Jamilloux","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.08.011_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0035","first-page":"74","article-title":"Ambivalence of CD4\u00a0lymphocytopenia in sarcoidosis","volume":"20","author":"Gentil","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.42.4.250","article-title":"Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response","volume":"42","author":"Hudspith","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.08.011_bib0045","first-page":"129","article-title":"Does peripheral blood T-lymphocyte population distribution in sarcoidosis provide a prognostic clue?","volume":"8","author":"Desrues","year":"1991","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0050","doi-asserted-by":"crossref","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19\u00a0lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2016.08.011_bib0055","doi-asserted-by":"crossref","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2016.08.011_bib0060","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2016.08.011_bib0065","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2016.08.011_bib0070","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248\u00a0patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0080","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4\u00a0decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.08.011_bib0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0034-1381229","article-title":"Clinical presentation of sarcoidosis and diagnostic work-up","volume":"35","author":"Valeyre","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1378\/chest.86.4.585","article-title":"Aspergillomas complicating sarcoidosis. A prospective study in 100\u00a0patients","volume":"86","author":"Wollschlager","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.08.011_bib0095","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.08.011_bib0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0761-8425(04)71582-X","article-title":"Infections opportunistes et sarco\u00efdose","volume":"21","author":"Girard","year":"2004","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.revmed.2016.08.011_bib0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/qjmed\/hct052","article-title":"Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18\u00a0cases","volume":"106","author":"Bernard","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.08.011_bib0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.revmed.2006.07.007","article-title":"Aspergilloses au cours de maladies syst\u00e9miques trait\u00e9es par cortico\u00efdes et\/ou immunosuppresseurs\u00a0: analyse de neuf cas et revue de la litt\u00e9rature","volume":"27","author":"Stankovic","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.08.011_bib0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"Denning","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.08.011_bib0120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.08.011_bib0125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2013.10.050","article-title":"Surgical therapy of pulmonary aspergillomas: a 30-year North American experience","volume":"97","author":"Muniappan","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.revmed.2016.08.011_bib0130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MCP.0000000000000075","article-title":"Advanced pulmonary sarcoidosis","volume":"20","author":"Valeyre","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0135","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1093\/cid\/cit600","article-title":"A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study","volume":"57","author":"Epaulard","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0140","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.12-1784","article-title":"A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma","volume":"143","author":"Kravitz","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.08.011_bib0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00408-011-9280-9","article-title":"Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature","volume":"189","author":"Pena","year":"2011","journal-title":"Lung"},{"key":"10.1016\/j.revmed.2016.08.011_bib0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MD.0b013e3181775a73","article-title":"Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis","volume":"87","author":"Hours","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2016.08.011_bib0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-87-3-336","article-title":"Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23\u00a0cases","volume":"87","author":"Delaney","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010\u00a0update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0170","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0175","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0180","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/archinte.1976.03630120008006","article-title":"The infectious complications of sarcoidosis: a current perspective","volume":"136","author":"Winterbauer","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0185","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2014.10.006","article-title":"The spectrum of opportunistic diseases complicating sarcoidosis","volume":"14","author":"Jamilloux","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2016.08.011_bib0195","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.07-0850","article-title":"Anti-endothelial cell antibodies in patients with sarcoidosis","volume":"133","author":"Inui","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.08.011_bib0200","first-page":"95","article-title":"Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection","volume":"28","author":"Gupta","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0970-2113.148467","article-title":"Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis","volume":"32","author":"Vyas","year":"2015","journal-title":"Lung India"},{"key":"10.1016\/j.revmed.2016.08.011_bib0210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.08.011_bib0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression","volume":"81","author":"Gheuens","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2016.08.011_bib0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28\u00a0cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0230","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57\u00a0cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.08.011_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.nrl.0000250948.04681.96","article-title":"Review of progressive multifocal leukoencephalopathy and natalizumab","volume":"12","author":"Aksamit","year":"2006","journal-title":"Neurologist"},{"key":"10.1016\/j.revmed.2016.08.011_bib0240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1378\/chest.83.3.572","article-title":"The association of progressive multifocal leukoencephalopathy and sarcoidosis","volume":"83","author":"Rosenbloom","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.08.011_bib0245","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1749-6632.1974.tb14469.x","article-title":"Our evolving understanding of progressive multifocal leukoencephalopathy","volume":"230","author":"Richardson","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2016.08.011_bib0250","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/13550280152537292","article-title":"Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside","volume":"7","author":"Aksamit","year":"2001","journal-title":"J Neurovirol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0255","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","article-title":"Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis","volume":"22","author":"De Luca","year":"2008","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.revmed.2016.08.011_bib0260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","article-title":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J Neurovirol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0265","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"Elphick","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.revmed.2016.08.011_bib0270","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.0b013e3181c0d4a1","article-title":"Determinants of survival in progressive multifocal leukoencephalopathy","volume":"73","author":"Marzocchetti","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.08.011_bib0275","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e318268465b","article-title":"Metabolic profile of PML lesions in patients with and without IRIS: an observational study","volume":"79","author":"Gheuens","year":"2012","journal-title":"Neurology"},{"issue":"Suppl. 10","key":"10.1016\/j.revmed.2016.08.011_bib0280","first-page":"47","article-title":"Nocardia, infections","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.revmed.2016.08.011_bib0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","article-title":"Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy","volume":"19","author":"Brown-Elliott","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.revmed.2016.08.011_bib0290","first-page":"94","article-title":"Herpes zoster in patients with sarcoidosis","volume":"59","author":"Miyagawa","year":"1992","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0295","first-page":"1360","article-title":"Fungal infections complicating pulmonary sarcoidosis","volume":"152","author":"Rubinstein","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00063198-199909000-00005","article-title":"Clinical courses and prognoses of pulmonary sarcoidosis","volume":"5","author":"Nagai","year":"1999","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.revmed.2016.08.011_bib0305","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/thx.38.8.572","article-title":"Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment","volume":"38","author":"Jewkes","year":"1983","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.08.011_bib0310","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1378\/chest.111.3.612","article-title":"Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals","volume":"111","author":"Addrizzo-Harris","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.08.011_bib0315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.revmed.2004.09.009","article-title":"Une manifestation inhabituelle de la sarco\u00efdose thoracique\u00a0: la cavit\u00e9 pulmonaire primaire","volume":"26","author":"Fajraoui","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.08.011_bib0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/13693780600575635","article-title":"Fatal hemoptysis from invasive Aspergillus niger in a patient with cavitary lung disease and Mycobacterium avium complex infection","volume":"44","author":"Gifford","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0325","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/jmm.0.46639-0","article-title":"Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus","volume":"55","author":"Dannaoui","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0330","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0761-8425(07)92760-6","article-title":"Aspergillose et sarcoidose","volume":"24","author":"Lachkar","year":"2007","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.revmed.2016.08.011_bib0335","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"Camuset","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.08.011_bib0340","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1590\/S1806-37132009000500015","article-title":"Aspergilloma formation in cavitary sarcoidosis","volume":"35","author":"Panjabi","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0345","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-3062.2011.00615.x","article-title":"Successful double lung transplantation in a patient with bilateral pulmonary and sinus aspergillomas","volume":"13","author":"Minces","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0350","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2010.3641","article-title":"A severe case of multisystem sarcoidosis complicated by aspergillosis and aspergillomas","volume":"2011","author":"Zoumot","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.revmed.2016.08.011_bib0355","first-page":"75","article-title":"Rapid improvement of osseous sarcoidosis after the treatment of pulmonary aspergillosis by itraconazole","volume":"28","author":"Murakami","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0360","first-page":"469","article-title":"AIRP best cases in radiologic-pathologic correlation: pulmonary sarcoidosis complicated by aspergilloma formation","volume":"32","author":"Kantartzis","year":"2012","journal-title":"Radiogr Rev"},{"key":"10.1016\/j.revmed.2016.08.011_bib0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thoraxjnl-2013-203988","article-title":"Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis","volume":"69","author":"Keir","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2016.08.011_bib0370","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pneumo.2012.12.001","article-title":"Nocardiose pulmonaire et sarco\u00efdose","volume":"69","author":"Rkiouak","year":"2013","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.revmed.2016.08.011_bib0375","first-page":"65","article-title":"Disseminated nocardiosis mimicking exacerbation of pulmonary sarcoidosis","volume":"30","author":"Zuk","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.08.011_bib0380","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurol.2008.06.012","article-title":"Abc\u00e8s c\u00e9r\u00e9braux \u00e0 Nocardia\u00a0: caract\u00e9ristiques radiocliniques et prise en charge th\u00e9rapeutique","volume":"165","author":"Marnet","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0385","first-page":"124","article-title":"Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome","volume":"15","author":"Gupta","year":"2008","journal-title":"Can Respir J"},{"key":"10.1016\/j.revmed.2016.08.011_bib0390","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0761-8425(06)71467-X","article-title":"Co-infection \u00e0 Mycobacterium tuberculosis et Pneumocystis jiroveci chez une patiente non infect\u00e9e par le VIH","volume":"23","author":"Filoche","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.revmed.2016.08.011_bib0395","first-page":"46","article-title":"Successful treatment of relapsing disseminated coccidioidomycosis with cutaneous involvement with posaconazole","volume":"7","author":"Wollina","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.revmed.2016.08.011_bib0400","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-4632.2004.02363.x","article-title":"Disseminated sporotrichosis mimicking sarcoidosis","volume":"45","author":"Yang","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2016.08.011_bib0405","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0399-077X(87)80051-3","article-title":"Une observation de leishmaniose chez un malade trait\u00e9 par cortico\u00efdes pour sarco\u00efdose","volume":"17","author":"Mulliez","year":"1987","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.revmed.2016.08.011_bib0410","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-0463.2006.apm_484.x","article-title":"Leishmania infection in a 51-year-old woman with sarcoidosis: case report","volume":"114","author":"Chianura","year":"2006","journal-title":"Acta Pathol Microbiol Immunol Scand"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316305252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316305252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:37:49Z","timestamp":1759336669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316305252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0248866316305252"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.08.011","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les infections opportunistes au cours de la sarco\u00efdose","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}